Shanda Group — Full Portfolio
7 tracked investments · listed companies and verified rows first
Cordance Medical develops medical technology focused on diagnosing and treating patients with brain diseases, drawing on expertise from neurosurgery, neuroimaging, and biomedical engineering.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtechMedical DevicesMountain View, US
Ryan Dittamore(CEO)in
Co-investorsAngel Physicians FundBeresford VenturesCreative Destruction Lab (CDL)SmartGateVCSonder CapitalR42
DigiFT is a regulated trading platform that uses decentralized finance to connect users with illiquid financial assets.
Crypto & Web3Fintech
Co-investorsMirana VenturesHash GlobalHashkey CapitalNorth Beta CapitalSBI Holdings
Lumus develops geometric reflective waveguide technology for near-eye displays used in augmented reality glasses, aiming for daylight-readable, energy-efficient displays in a normal eyewear form factor.
Deep TechHardwareNew Materials
Co-investorsJerusalem Global VenturesHTC
Thryve provides a platform that enables partners to improve patient engagement, preventive care, and clinical research through real-world health insights and insurance innovation.
Data & InfrastructureDigital HealthHealthtechBerlin, DE
Friedrich Lämmel(CEO)inJohn Trimpop(CTO)Paul Burggraf(COO)in
Co-investorsCARMA FUNDKickstart InnovationAbstract VenturesDarling VenturesJoyance PartnersTMV+2 more
THRYVE Automation designs and builds custom turnkey automation systems—including robotics, machine vision, material handling, inspection, and packaging—for manufacturers in energy, life sciences, HVAC/filtration, automotive, and consumer products.
Advanced ManufacturingHardwareRoboticsRichmond, US
Co-investorsMcNally CapitalAbstract VenturesDarling VenturesJoyance PartnersTMVUnilever Ventures+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.